Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1599, 2007-01, pp. : 5-5
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Antihypertensive/DM link weakest for ARAs, ACE inhibitors
Reactions Weekly, Vol. 1, Iss. 1136, 2007-01 ,pp. :
Access to resources
Recommend
DPP-IV inhibitors could be cost-effective for T2DM
Inpharma, Vol. 1, Iss. 1642, 2008-01 ,pp. :
DPP-IV inhibitors could be cost-effective for T2DM
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 556, 2008-01 ,pp. :
Current and Future Treatment Directions in T2DM
Inpharma, Vol. 1, Iss. 1607, 2007-01 ,pp. :
Pioglitazone improves measures of T2DM and dyslipidaemia
Inpharma, Vol. 1, Iss. 1607, 2007-01 ,pp. :